Skip to main content
. 2022 Aug 18;17(8):e0273247. doi: 10.1371/journal.pone.0273247

Table 1. Characteristics of sepsis patients and age-matched healthy volunteers.

Sepsis patients Healthy volunteers
Age [years] 61.5 ± 14.9 56.5 ± 8.5
Sex        Men [n; %] 36; 59 7, 54
Women        [n; %] 25; 41 6, 46
Heart rate [min-1] 104 ± 25 68 ± 6
Systolic arterial pressure [mmHg] 108 ± 20 134 ± 14
Diastolic arterial pressure [mmHg] 53 ± 13 83 ± 5
Mean arterial pressure [mmHg] 72 ± 14 100 ± 6
Leukocyte concentration [/nl] 20.7 ± 17.4 6.6 ± 1.1
Monocyte concentration [/μl] 569 ± 99 532 ± 51
IL-6 [pg/ml] 108.4 [29.1 | 266.7] 1.0 [0.76 | 1.06]
TNF [pg/ml] 5.8 [4.0 | 10.3] 2.1 [0.33 | 3.48]
IL-10 [pg/ml] 4.3 [1.2 | 14.0] 0.9 [0.36 | 1.06]
IL-8 [pg/ml] 43.8 [19.6 | 142.6] 7.9 [4.12 | 11.83]
IL-1β [pg/ml] 0.7 [0.6 | 1.8] 1.4 [0.72 | 1.44]
IL-1α [pg/ml] 0.6 [0.23 | 2.31] 1.2 [1.06 | 1.27]
Case fatality rate [%] 49
ICU stay, survivors [days] 31 ± 36
ICU stay, deceased [days] 16 ± 23
SOFA-Score [median] 12 [11 | 14]
SAPS-II Score [median] 72 [59 | 79]
≥2 qSOFA criteria [%] 65.6
≥2 SIRS criteria [%] 82
Shocka [%] 56
Patients with i.v. catecholamine therapy [%] 91
Patients with i.v. catecholamine therapy ≥ 0.1 μg/kg body weight / min [%] 56
Lactate serum concentration [mmol/l] 3.6 ± 4.1
Patients on mechanical ventilation (%) 80
PaO2/ FiO2 ratio (mmHg) 184 ± 101
Platelet concentration [/nl] 198 ± 157
Bilirubin serum concentration [mg/dl] 2.4 ± 6.2
Creatinine serum concentration [mg/dl] 1.9 ± 1.6
Patients under renal replacement therapy [n; %] 15; 25
C-reactive protein serum concentration [mg/l] 20.3 ± 12.1
Procalcitonin serum concentration [μg/l] 27.7 ± 89.4

Data from 61 septic patients within 24 h of meeting Sepsis-3 criteria [10] and 12 age-matched healthy volunteers presented as numbers, percentages, or means ± SD. SOFA, SAPS-II score, and cytokine concentrations presented as median [first quartile | third quartile]. aDefinition of septic shock as in [10]; i.e., sepsis with a serum lactate concentration >2 mmol/l and any vasopressor therapy to sustain a mean arterial pressure ≥65 mmHg.